MX2020001598A - Inhibidores selectivos de proteína arginina metiltransferasa 5 (prmt5). - Google Patents
Inhibidores selectivos de proteína arginina metiltransferasa 5 (prmt5).Info
- Publication number
- MX2020001598A MX2020001598A MX2020001598A MX2020001598A MX2020001598A MX 2020001598 A MX2020001598 A MX 2020001598A MX 2020001598 A MX2020001598 A MX 2020001598A MX 2020001598 A MX2020001598 A MX 2020001598A MX 2020001598 A MX2020001598 A MX 2020001598A
- Authority
- MX
- Mexico
- Prior art keywords
- prmt5
- selective inhibitors
- protein arginine
- arginine methyltransferase
- methyltransferase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/14—Pyrrolo-pyrimidine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762543141P | 2017-08-09 | 2017-08-09 | |
| US201862630581P | 2018-02-14 | 2018-02-14 | |
| US201862664442P | 2018-04-30 | 2018-04-30 | |
| PCT/US2018/046057 WO2019032859A1 (en) | 2017-08-09 | 2018-08-09 | SELECTIVE INHIBITORS OF THE PROTEIN ARGININE METHYLTRANSFERASE 5 (PRMT5) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2020001598A true MX2020001598A (es) | 2020-10-28 |
Family
ID=63405398
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2020001598A MX2020001598A (es) | 2017-08-09 | 2018-08-09 | Inhibidores selectivos de proteína arginina metiltransferasa 5 (prmt5). |
Country Status (18)
| Country | Link |
|---|---|
| US (4) | US10570140B2 (https=) |
| EP (2) | EP3939986A1 (https=) |
| JP (1) | JP2020530496A (https=) |
| KR (1) | KR20200036922A (https=) |
| CN (1) | CN111527099B (https=) |
| AU (1) | AU2018313910B2 (https=) |
| BR (1) | BR112020002736A2 (https=) |
| CA (1) | CA3072439A1 (https=) |
| DK (1) | DK3665179T3 (https=) |
| ES (1) | ES2885180T3 (https=) |
| IL (1) | IL272519B (https=) |
| MA (1) | MA49840A (https=) |
| MX (1) | MX2020001598A (https=) |
| PL (1) | PL3665179T3 (https=) |
| PT (1) | PT3665179T (https=) |
| UA (1) | UA126481C2 (https=) |
| WO (1) | WO2019032859A1 (https=) |
| ZA (1) | ZA202000773B (https=) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3939986A1 (en) * | 2017-08-09 | 2022-01-19 | Prelude Therapeutics, Incorporated | Selective inhibitors of protein arginine methyltransferase 5 (prmt5) |
| AU2019235912B2 (en) * | 2018-03-14 | 2024-03-21 | Prelude Therapeutics, Incorporated | Selective inhibitors of protein arginine methyltransferase 5 (PRMT5) |
| US10711007B2 (en) | 2018-03-14 | 2020-07-14 | Prelude Therapeutics Incorporated | Selective inhibitors of protein arginine methyltransferase 5 (PRMT5) |
| US11077101B1 (en) | 2018-07-18 | 2021-08-03 | Tango Therapeutics, Inc. | Compounds and methods of use |
| US12552826B2 (en) | 2018-08-07 | 2026-02-17 | Merck Sharp & Dohme Llc | PRMT5 inhibitors |
| US12173026B2 (en) * | 2018-08-07 | 2024-12-24 | Merck Sharp & Dohme Llc | PRMT5 inhibitors |
| EP3924360A1 (en) * | 2019-02-13 | 2021-12-22 | Prelude Therapeutics, Incorporated | Selective inhibitor of protein arginine methyltransferase 5 (prmt5) |
| IL318073A (en) * | 2019-03-25 | 2025-02-01 | California Inst Of Techn | PRMT5 inhibitors and their uses |
| JP2022526604A (ja) * | 2019-04-05 | 2022-05-25 | プレリュード・セラピューティクス・インコーポレイテッド | タンパク質アルギニンメチルトランスフェラーゼ５の選択的阻害剤 |
| WO2020206289A1 (en) * | 2019-04-05 | 2020-10-08 | Prelude Therapeutics, Incorporated | Selective inhibitors of protein arginine methyltransferase 5 |
| CN114126614A (zh) * | 2019-05-30 | 2022-03-01 | 安杰斯制药公司 | 作为prmt5抑制剂的杂环化合物 |
| WO2021055797A1 (en) * | 2019-09-18 | 2021-03-25 | Prelude Therapeutics, Incorporated | Selective inhibitors of protein arginine methyltransferase 5 (prmt5) |
| EP4048674A2 (en) * | 2019-10-21 | 2022-08-31 | Accent Therapeutics, Inc. | Mettl3 modulators |
| KR20220086628A (ko) * | 2019-10-22 | 2022-06-23 | 루핀 리미티드 | Prmt5 저해제의 약학적 조합물 |
| US12403137B2 (en) | 2019-10-28 | 2025-09-02 | Tango Therapeutics, Inc. | Compounds and methods of use |
| WO2022026892A1 (en) | 2020-07-31 | 2022-02-03 | Tango Therapeutics, Inc. | Piperidin-1- yl-n-pyrydi ne-3-yl-2-oxoacet am ide derivatives useful for the treatment of mtap-deficient and/or mt a-accumulating cancers |
| US11685744B2 (en) | 2020-09-21 | 2023-06-27 | Prelude Therapeutics Incorporated | CDK inhibitors and their use as pharmaceuticals |
| US20220251088A1 (en) * | 2020-12-10 | 2022-08-11 | Prelude Therapeutics, Incorporated | Processes for Making PRMT5 Inhibitors |
| UY39565A (es) * | 2020-12-16 | 2022-06-30 | Amgen Inc | Inhibidores de prmt5 novedosos |
| CA3205652A1 (en) | 2020-12-18 | 2022-06-23 | Prelude Therapeutics Incorporated | Cdk inhibitors and their use as pharmaceuticals |
| CN117157297A (zh) * | 2021-07-20 | 2023-12-01 | 上海齐鲁制药研究中心有限公司 | Prmt5抑制剂 |
| US20230181589A1 (en) * | 2021-12-03 | 2023-06-15 | The Trustees Of Indiana University | Prmt5 inhibitors for ocular therapy |
| US11939340B2 (en) | 2022-01-21 | 2024-03-26 | Prelude Therapeutics Incorporated | CDK inhibitors and their use as pharmaceuticals |
| WO2023150612A1 (en) | 2022-02-03 | 2023-08-10 | Prelude Therapeutics, Incorporated | Cdk inhibitors and their use as pharmaceuticals |
| US20240018136A1 (en) | 2022-03-09 | 2024-01-18 | Prelude Therapeutics, Incorporated | CDK Inhibitors And Their Use As Pharmaceuticals |
| CA3245813A1 (en) | 2022-03-23 | 2023-09-28 | Prelude Therapeutics, Incorporated | POLYMORPHIC COMPOUNDS AND THEIR USES |
| CN116655638B (zh) * | 2022-05-12 | 2024-01-26 | 上海齐鲁制药研究中心有限公司 | 氘代prmt5抑制剂 |
| US20240150340A1 (en) | 2022-10-06 | 2024-05-09 | Prelude Therapeutics Incorporated | CDK Inhibitors And Their Use As Pharmaceuticals |
| WO2024216249A1 (en) | 2023-04-14 | 2024-10-17 | Prelude Therapeutics Incorporated | Cdk inhibitors and their use as pharmaceuticals |
| CN116554194A (zh) * | 2023-05-23 | 2023-08-08 | 江苏八巨药业有限公司 | 一种卡培他滨中间体的合成方法 |
| WO2025064402A1 (en) * | 2023-09-22 | 2025-03-27 | St. Jude Children's Research Hospital, Inc. | Method for treating sickle cell disease by targeting senescent cells |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3657744A (en) | 1970-05-08 | 1972-04-25 | Univ Minnesota | Method for fixing prosthetic implants in a living body |
| US4733665C2 (en) | 1985-11-07 | 2002-01-29 | Expandable Grafts Partnership | Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft |
| US5023252A (en) | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
| US5040548A (en) | 1989-06-01 | 1991-08-20 | Yock Paul G | Angioplasty mehtod |
| US5350395A (en) | 1986-04-15 | 1994-09-27 | Yock Paul G | Angioplasty apparatus facilitating rapid exchanges |
| US5061273A (en) | 1989-06-01 | 1991-10-29 | Yock Paul G | Angioplasty apparatus facilitating rapid exchanges |
| US4748982A (en) | 1987-01-06 | 1988-06-07 | Advanced Cardiovascular Systems, Inc. | Reinforced balloon dilatation catheter with slitted exchange sleeve and method |
| US4992445A (en) | 1987-06-12 | 1991-02-12 | American Cyanamid Co. | Transdermal delivery of pharmaceuticals |
| US5001139A (en) | 1987-06-12 | 1991-03-19 | American Cyanamid Company | Enchancers for the transdermal flux of nivadipine |
| CA1322628C (en) | 1988-10-04 | 1993-10-05 | Richard A. Schatz | Expandable intraluminal graft |
| US6344053B1 (en) | 1993-12-22 | 2002-02-05 | Medtronic Ave, Inc. | Endovascular support device and method |
| US5674278A (en) | 1989-08-24 | 1997-10-07 | Arterial Vascular Engineering, Inc. | Endovascular support device |
| US5292331A (en) | 1989-08-24 | 1994-03-08 | Applied Vascular Engineering, Inc. | Endovascular support device |
| DE102010060118A1 (de) * | 2010-10-22 | 2012-04-26 | Röhm Gmbh | Stirnseitenmitnehmer |
| US9145438B2 (en) | 2010-12-03 | 2015-09-29 | Epizyme, Inc. | 7-deazapurine modulators of histone methyltransferase, and methods of use thereof |
| ES2637113T3 (es) * | 2011-01-10 | 2017-10-10 | Infinity Pharmaceuticals, Inc. | Procedimientos para preparar isoquinolinonas y formas sólidas de isoquinolinonas |
| US9464065B2 (en) | 2011-03-24 | 2016-10-11 | The Scripps Research Institute | Compounds and methods for inducing chondrogenesis |
| DK2935222T3 (en) * | 2012-12-21 | 2019-01-07 | Epizyme Inc | PRMT5 INHIBITORS AND APPLICATIONS THEREOF |
| WO2014153214A1 (en) * | 2013-03-14 | 2014-09-25 | Epizyme, Inc. | Arginine methyl transferase inhibtors and uses thereof |
| CA2942833A1 (en) * | 2013-03-15 | 2014-09-18 | Ohio State Innovation Foundation | Inhibitors of prmt5 and methods of their use |
| US20170198006A1 (en) * | 2014-06-25 | 2017-07-13 | Epizyme, Inc. | Prmt5 inhibitors and uses thereof |
| US20170210751A1 (en) * | 2014-06-25 | 2017-07-27 | Epizyme, Inc. | Prmt5 inhibitors and uses thereof |
| WO2016066582A1 (en) | 2014-10-28 | 2016-05-06 | Bci Pharma | Nucleoside kinase inhibitors |
| KR101719881B1 (ko) * | 2014-12-22 | 2017-03-24 | 삼성전기주식회사 | 렌즈 모듈 |
| MX2017010844A (es) * | 2015-02-24 | 2017-12-07 | Pfizer | Derivados de nucleosidos sustituidos utiles como agentes anticancerosos. |
| AR104326A1 (es) | 2015-05-04 | 2017-07-12 | Lilly Co Eli | Compuestos nucleósidos 5-sustituidos |
| TWI870767B (zh) * | 2015-08-26 | 2025-01-21 | 比利時商健生藥品公司 | 使用作為prmt5抑制劑之新穎經6-6雙環芳香環取代之核苷類似物 |
| AU2017230658B2 (en) | 2016-03-10 | 2021-03-04 | Janssen Pharmaceutica Nv | Substituted nucleoside analogues for use as PRMT5 inhibitors |
| WO2017218802A1 (en) | 2016-06-15 | 2017-12-21 | Prelude Therapeutics, Incorporated | Selective inhibitors of protein arginine methyltransferase 5 (prmt5) |
| WO2018065365A1 (en) | 2016-10-03 | 2018-04-12 | Janssen Pharmaceutica Nv | Novel monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as prmt5 inhibitors |
| WO2018075601A1 (en) | 2016-10-18 | 2018-04-26 | Prelude Therapeutics, Incorporated | Selective inhibitors of protein arginine methyltransferase 5 (prmt5) |
| WO2018085833A2 (en) | 2016-11-07 | 2018-05-11 | Prelude Therapeutics, Incorporated | Selective inhibitors of protein arginine methyl transferase 5 (prmt5) |
| WO2018085818A1 (en) | 2016-11-07 | 2018-05-11 | Prelude Therapeutics, Incorporated | Selective inhibitors of protein arginine methyltransferase 5 (prmt5) |
| US11220524B2 (en) | 2017-02-20 | 2022-01-11 | Prelude Therapeutics Incorporated | Selective inhibitors of protein arginine methyltransferase 5 (PRMT5) |
| WO2018152501A1 (en) | 2017-02-20 | 2018-08-23 | Prelude Therapeutics, Incorporated | Selective inhibitors of protein arginine methyltransferase 5 (prmt5) |
| WO2018160824A1 (en) | 2017-03-01 | 2018-09-07 | Prelude Therapeutics, Incorporated | Selective inhibitors of protein arginine methyltransferase 5 (prmt5) |
| WO2018160855A1 (en) | 2017-03-01 | 2018-09-07 | Prelude Therapeutics, Incorporated | Selective inhibitors of protein arginine methyltransferase 5 (prmt5) |
| EP3939986A1 (en) | 2017-08-09 | 2022-01-19 | Prelude Therapeutics, Incorporated | Selective inhibitors of protein arginine methyltransferase 5 (prmt5) |
| WO2019084470A1 (en) | 2017-10-26 | 2019-05-02 | Prelude Therapeutics, Incorporated | SELECTIVE INHIBITORS OF THE PROTEIN ARGININE METHYLTRANSFERASE 5 (PRMT5) |
| US12552826B2 (en) | 2018-08-07 | 2026-02-17 | Merck Sharp & Dohme Llc | PRMT5 inhibitors |
-
2018
- 2018-08-09 EP EP21178139.8A patent/EP3939986A1/en not_active Withdrawn
- 2018-08-09 MA MA049840A patent/MA49840A/fr unknown
- 2018-08-09 BR BR112020002736-7A patent/BR112020002736A2/pt not_active Application Discontinuation
- 2018-08-09 PL PL18760136T patent/PL3665179T3/pl unknown
- 2018-08-09 WO PCT/US2018/046057 patent/WO2019032859A1/en not_active Ceased
- 2018-08-09 EP EP18760136.4A patent/EP3665179B1/en active Active
- 2018-08-09 CN CN201880065979.7A patent/CN111527099B/zh not_active Expired - Fee Related
- 2018-08-09 ES ES18760136T patent/ES2885180T3/es active Active
- 2018-08-09 DK DK18760136.4T patent/DK3665179T3/da active
- 2018-08-09 PT PT187601364T patent/PT3665179T/pt unknown
- 2018-08-09 KR KR1020207006384A patent/KR20200036922A/ko not_active Ceased
- 2018-08-09 CA CA3072439A patent/CA3072439A1/en active Pending
- 2018-08-09 JP JP2020530436A patent/JP2020530496A/ja not_active Ceased
- 2018-08-09 US US16/059,909 patent/US10570140B2/en active Active
- 2018-08-09 AU AU2018313910A patent/AU2018313910B2/en not_active Ceased
- 2018-08-09 UA UAA202000927A patent/UA126481C2/uk unknown
- 2018-08-09 MX MX2020001598A patent/MX2020001598A/es unknown
-
2020
- 2020-01-16 US US16/744,771 patent/US11078205B2/en not_active Expired - Fee Related
- 2020-02-05 ZA ZA2020/00773A patent/ZA202000773B/en unknown
- 2020-02-06 IL IL272519A patent/IL272519B/en unknown
- 2020-08-05 US US16/985,643 patent/US11208416B2/en not_active Expired - Fee Related
-
2021
- 2021-11-18 US US17/529,781 patent/US20220153747A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| MA49840A (fr) | 2020-06-17 |
| UA126481C2 (uk) | 2022-10-12 |
| ZA202000773B (en) | 2022-07-27 |
| ES2885180T3 (es) | 2021-12-13 |
| CN111527099B (zh) | 2024-03-22 |
| PT3665179T (pt) | 2021-09-10 |
| EP3939986A1 (en) | 2022-01-19 |
| WO2019032859A1 (en) | 2019-02-14 |
| KR20200036922A (ko) | 2020-04-07 |
| US20200361946A1 (en) | 2020-11-19 |
| US20220153747A1 (en) | 2022-05-19 |
| US20190048014A1 (en) | 2019-02-14 |
| EP3665179A1 (en) | 2020-06-17 |
| CA3072439A1 (en) | 2019-02-14 |
| BR112020002736A2 (pt) | 2020-07-28 |
| IL272519B (en) | 2022-05-01 |
| CN111527099A (zh) | 2020-08-11 |
| US11078205B2 (en) | 2021-08-03 |
| DK3665179T3 (da) | 2021-08-16 |
| IL272519A (en) | 2020-03-31 |
| AU2018313910A1 (en) | 2020-03-05 |
| EP3665179B1 (en) | 2021-06-09 |
| JP2020530496A (ja) | 2020-10-22 |
| AU2018313910B2 (en) | 2022-12-08 |
| US10570140B2 (en) | 2020-02-25 |
| PL3665179T3 (pl) | 2021-11-29 |
| US20200148692A1 (en) | 2020-05-14 |
| US11208416B2 (en) | 2021-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2020001598A (es) | Inhibidores selectivos de proteína arginina metiltransferasa 5 (prmt5). | |
| ZA202005325B (en) | Selective inhibitors of protein arginine methyltransferase 5 (prmt5) | |
| PH12018502747A1 (en) | Boronic acid derivatives and therapeutic uses thereof | |
| PH12022550399A1 (en) | MTA-Cooperative PRMT5 Inhibitors | |
| MX2021005463A (es) | Derivados de espiro-sulfonamida como inhibidores de la proteina de leucemia de celula mieloide 1 (mcl-1). | |
| TN2018000276A1 (en) | Inhibitors of receptor-interacting protein kinase 1. | |
| MY186547A (en) | 4?-fluoro-2?-methyl substituted nucleoside derivatives | |
| PH12020550703A1 (en) | Sulfonamide compounds and use thereof | |
| MX2020007945A (es) | Proteinas f del rsv estabilizadas y usos de las mismas. | |
| NZ739676A (en) | Heteroaryl compounds as irak inhibitors and uses thereof | |
| EA201791563A1 (ru) | Замещенные нуклеозидные производные, полезные в качестве агентов против рака | |
| EA201791692A1 (ru) | 4H-ПИРРОЛО[3,2-c]ПИРИДИН-4-ОНОВЫЕ ПРОИЗВОДНЫЕ | |
| MY189761A (en) | Quinazoline derivatives used to treat hiv | |
| JO3794B1 (ar) | المركبات متعددة الحلقات كمثبطات لتيروزين كيناز بروتون | |
| PH12015502041B1 (en) | Heteroaryl compounds and uses thereof | |
| MX381487B (es) | Ciertos inhibidores de la proteina quinasa. | |
| EA201890247A1 (ru) | Ингибиторы дезоксиуридинтрифосфатазы, содержащие гидантоин | |
| MX386700B (es) | Inhibidores de la tirosina quinasa de bruton y metodos de su uso. | |
| MX2022002946A (es) | Inhibidores de cdk y su uso como productos farmaceuticos. | |
| PH12021550382A1 (en) | Tetrahydropyridopyrimidine derivatives as ahr modulators | |
| MX2020006596A (es) | Hidroxiisoxazolinas y derivados de estos. | |
| WO2018085833A3 (en) | Selective inhibitors of protein arginine methyl transferase 5 (prmt5) | |
| ZA202105887B (en) | Selective inhibitor of protein arginine methyltransferase 5 (prmt5) | |
| PH12015502589A1 (en) | 4`-azido, 3`-deoxy-3`-fluoro substituted nucleoside derivatives | |
| CA3056612A1 (en) | Analogs of deutetrabenazine, their preparation and use |